CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 ST-Segment Elevation Myocardial Infarction Patients in the Coronary Care Unit Is it Time to Break Old Habits? Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Cardiac Shock Care Centers: JACC Review Topic of the Week

Original Research13 Sep 2021

JOURNAL:Circ Res. Article Link

Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4

MM Liu, M Yan, D Ai et al. Keywords: post infarction; myocardial infarction; inhibition of inflammation; macrophage

Full Text PDF